首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2252篇
  免费   69篇
  国内免费   17篇
耳鼻咽喉   7篇
儿科学   79篇
妇产科学   29篇
基础医学   129篇
口腔科学   34篇
临床医学   284篇
内科学   368篇
皮肤病学   24篇
神经病学   99篇
特种医学   44篇
外科学   155篇
综合类   102篇
预防医学   593篇
眼科学   17篇
药学   244篇
  1篇
中国医学   56篇
肿瘤学   73篇
  2023年   99篇
  2022年   121篇
  2021年   178篇
  2020年   161篇
  2019年   199篇
  2018年   140篇
  2017年   98篇
  2016年   48篇
  2015年   62篇
  2014年   144篇
  2013年   177篇
  2012年   130篇
  2011年   133篇
  2010年   95篇
  2009年   92篇
  2008年   82篇
  2007年   86篇
  2006年   51篇
  2005年   34篇
  2004年   32篇
  2003年   22篇
  2002年   17篇
  2001年   13篇
  2000年   12篇
  1999年   12篇
  1998年   9篇
  1997年   11篇
  1996年   6篇
  1995年   3篇
  1994年   5篇
  1993年   2篇
  1992年   4篇
  1991年   5篇
  1990年   2篇
  1988年   1篇
  1987年   2篇
  1985年   9篇
  1984年   5篇
  1983年   1篇
  1982年   6篇
  1981年   4篇
  1980年   5篇
  1979年   2篇
  1978年   2篇
  1977年   1篇
  1976年   5篇
  1975年   1篇
  1974年   4篇
  1973年   2篇
  1970年   1篇
排序方式: 共有2338条查询结果,搜索用时 15 毫秒
1.
目的 基于《国际疾病分类》第11次修订本(ICD-11)、《国际功能、残疾和健康分类》(ICF)和《国际健康干预分类》(ICHIβ-3),探讨言语流畅性障碍的诊断标准和功能评估,分析言语流畅性障碍的主要评估内容,构建整体康复干预方案。方法 基于ICD-11和ICF分析言语流畅性障碍相关疾病及功能诊断标准;根据ICF的理论,分析言语流畅性障碍评估的主要内容和评估指标;依据ICF和ICHIβ-3构建言语流畅性障碍整体化与结构化康复干预方案。结果 根据ICD-11,言语流畅性障碍属6A01.1发育性言语流畅性障碍,相关疾病涉及6A01.0发育性语音障碍、6A01.2发育性语言障碍、脑性瘫痪等,以及MA80.0失语、MA80.1语言困难和失语、MA80.2构音障碍等。根据ICF,言语流畅性障碍主要涉及s3涉及发声和言语的结构,b3发声和言语功能,特别是b330言语的流畅和节奏功能,以及d1学习和应用知识,d3交流,d7人际交往和人际关系,d9社区、社会和公民生活,特别是d330说、d350交谈、d355讨论和d360使用交流设备与技术等。结构化的言语流畅性障碍康复干预方案主要涉及身体结构和功能、活动和参与以及环境因素三个方面,方法包括评估类、训练治疗类、教育咨询和社会与心理支持类等。结论 构建了言语流畅性障碍的诊断、评估和康复理论架构。  相似文献   
2.
The discovery of hepatitis C has been a landmark in public health as it brought the opportunity to save millions of lives through the diagnosis, prevention and cure of the disease. The combined work of three researchers, Alter H, Houghton M and Rice C, which set the basis for the diagnosis, treatment and prevention of hepatitis C apart from laying the ground work for a new approach to study infections in general and developing new antiviral agents. This is a story of a transfusion-associated infection. A series of clinical studies demonstrated the existence of an infectious agent associated with hepatitis. That was followed by the identification of what was later known to be the hepatitis C virus (HCV) and the development of diagnostic tests. It all preceded the full molecular identification and demonstration of a causal effect. Finally it ended up with the development and discovery of a new class of therapeutic drugs, the direct acting antivirals, which are now used not only to cure the disease but most probably, to eliminate the problem. This work started with Dr Alter H who demonstrated that a new virus was responsible for the majority of post-transfusion hepatitis followed by Houghton M who cloned the virus and developed the blood test to identify those cases that carried the virus. Finally, the work of Rice C demonstrated that a cloned HCV produced after applying molecular biology techniques could cause long-standing infection and cause the same disease as the one observed in humans.  相似文献   
3.
4.
5.
The present study aimed to investigate the association of A-kinase interacting protein 1 (AKIP1) with clinical characteristics, and further explore the prognostic value of AKIP1 in glioma patients.Totally 168 glioma patients who underwent tumor resection were analyzed, and their tumor tissue specimens were acquired for the detection of AKIP1 expression by immunohistochemistry (IHC), which was scored by a semi-quantitative method considering staining intensity and staining density.According to AKIP1 expression in tumor tissues of glioma patients, there were 65 (38.7%) patients with AKIP1 low expression (IHC score 0–3), 48 (28.6%) patients with AKIP1 high + expression (IHC score 4–6), 42 (25.0%) patients with AKIP1 high++ expression (IHC score 7–9) and 13 (7.7%) patients with AKIP1 high+++ expression (IHC score 10–12), respectively. AKIP1 expression was positively associated with World Health Organization grade. Overall survival (OS) was the lowest in the patients with AKIP1 high+++ expression, followed by those with AKIP1 high++ expression and those with AKIP1 high+ expression, and highest in those with AKIP1 low expression. Further subgroup analysis exhibited that AKIP1 expression was negatively associated with OS especially in high-grade glioma patients. In addition, AKIP1 expression was negatively associated with OS in all subgroups of patients with/without adjuvant radiotherapy, with/without adjuvant chemotherapy. Further multivariate Cox''s regression exhibited that AKIP1 high expression was an independent predictive factor for worse OS.AKIP1 presents with the potential to be a novel biomarker for tumor management and prognosis surveillance in glioma patients.  相似文献   
6.
目的基于世界卫生组织国际健康分类家族(WHO-FICs)架构,分析重症患者活动功能康复。  相似文献   
7.
《Enfermería clínica》2021,31(5):323-327
Buurtzorg Nederland is a Dutch healthcare organization in which nursing teams provide home care in all the skills that affect their profession. This article raises some questions regarding more internal aspects of the organization based on 3 dimensions. The first, the organizational dimension, in which the teams are structured based on 8 roles, without hierarchies and supported by the coaching system. The second, the nursing dimension, in which it is highlighted that nurses deal with all the competences that affect their profession, from basic care to more complex care, with the aim of defragmenting care. And the third, the economic dimension, in which it stands out that the sustainability of the organization is in being a system without managers, of small teams that work in small geographic areas, with a computer system that supports all organizational matters, healthcare and financial.The main characteristics of Buurtzorg Nederland are the self-management of the teams and the defragmented care that both the nurse and the patient satisfy. However, this defragmentation has been achieved in terms of patient care, with the same team attending to all basic and complex care needs at home, but at other levels of care it has not been achieved, and the patient must visit other providers, therefore, health care at other levels continues to be fragmented.  相似文献   
8.
目的: 探索围着床期小鼠子宫内膜自噬情况。方法: 选择36只ICR妊娠小鼠随机分为空白组、胚胎着床障碍模型组,每组小鼠18只。模型组采用米非司酮制备,每组每日予以生理盐水灌胃,分别于妊娠第4、5、6天脱颈处死小鼠各6只。观察子宫形态,计算各组平均胚胎着床位点数,检测自噬标志物微管相关轻链蛋白3-Ⅱ(LC3-Ⅱ),透射电镜观察子宫内膜细胞中自噬小体的表达。结果: 空白组妊娠第4天(pd4)子宫无明显串珠样改变,妊娠第5天(pd5)、妊娠第6天(pd6)子宫串珠样改变明显且分布均匀。模型组pd4、pd5未见明显串珠样改变,pd6可见少量串珠稀疏分布。空白组pd6的胚胎着床位点数较pd4增多,差异有统计学意义(P<0.05);而pd5的胚胎着床位点数与pd4比较有增多,但差异无统计学意义(P>0.05)。模型组pd5、pd6平均胚胎着床位点数分别低于空白组pd5、pd6(P<0.05,P<0.01)。2组LC3-Ⅱ蛋白水平差异无统计学意义(P>0.05)。透射电镜下空白组小鼠子宫内膜细胞完整,pd5自噬小体数量较pd4减少,pd6又增多。模型组部分细胞损伤、坏死,pd4自噬小体表达较空白组多,亦较模型组pd5、pd6多。结论: 自噬参与并调控胚胎着床过程,自噬异常可能破坏子宫内膜细胞活性和功能,影响胚胎着床。  相似文献   
9.
The odontogenic keratocyst (OKC) is a potentially aggressive odontogenic lesion and there is an ongoing debate regarding its biological behavior and classification. The present systematic review aims to assess the expression of the p53 protein in the odontogenic keratocyst in comparison to the dentigerous cyst and ameloblastoma.We searched MEDLINE, Web of Science and Scopus for immunohistochemical studies reporting OKC's, dentigerous cysts and solid/multicystic ameloblastomas. The Risk Difference between the lesions expressing the p53 was the effect measure and a P value < 0.05 was considered to provide evidence to the effect estimates.Results: The first hit retrieved 126 records. After duplicates removal, there were 84 articles, of which eighteen were assessed for eligibility. Thirteen articles were included in the meta-analysis, showing that OKC's have an estimated difference of 23% (P < 0.003) in the probability to express the p53 over dentigerous cysts, and an estimated difference of 4% (P = 0.28) in the probability to express the p53 over ameloblastomas.OKCs seem to behave more similarly to a tumor rather than an odontogenic cyst regarding its p53 expression and the classification of this lesion into Keratocystic Odontogenic Tumor should be carefully revaluated.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号